SLS

SELLAS Life Sciences Group (SLS)

About SELLAS Life Sciences Group (SLS)

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Details

Daily high

$2.31

Daily low

$2.03

Price at open

$2.03

52 Week High

$2.48

52 Week Low

$0.83

Market cap

290.6M

Dividend yield

0.00%

Volume

7.4M

Avg. volume

4.7M

P/E ratio

-7.11

SELLAS Life Sciences Group News

Details

Daily high

$2.31

Daily low

$2.03

Price at open

$2.03

52 Week High

$2.48

52 Week Low

$0.83

Market cap

290.6M

Dividend yield

0.00%

Volume

7.4M

Avg. volume

4.7M

P/E ratio

-7.11